South Korea Asthma Monitoring Devices Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Peak Flow Meters, Smart Inhalers, Nebulizers, Wearable Devices, and Others), By Technology (Digital, Manual), and South Korea Asthma Monitoring Devices Market Insights, Industry Trend, Forecasts to 2035

Industry: Healthcare

RELEASE DATE Aug 2025
REPORT ID SI15355
PAGES 139
REPORT FORMAT PathSoft

South Korea Asthma Monitoring Devices Market Insights Forecasts to 2035

  • The South Korea Asthma Monitoring Devices Market Size is Expected to Grow at a CAGR of around 5.5% from 2025 to 2035
  • The South Korea Asthma Monitoring Devices Market Size is Expected to Hold a Significant Share by 2035

South Korea Asthma Monitoring Devices Market

Get more details on this report -

Request Free Sample PDF

According to a Research Report Published by Spherical Insights & Consulting, the South Korea Asthma Monitoring Devices Market Size is Anticipated to Grow at a CAGR of 5.5% from 2025 to 2035. The market is driven by rising asthma prevalence and growing adoption of connected respiratory tools for home-based care. Expanding telehealth programs, smartphone integration, and payer focus on reducing hospitalizations further accelerate market growth.

 

Market Overview

The South Korea asthma monitoring devices market represents the sector in the healthcare market focused on medical devices and digital solutions that track, measure, and manage asthma symptoms through continuous measurement. Peak flow meters, spirometers, smart inhalers with sensors, and wearable respiratory monitors provide continuous and real-time measurements for patients and healthcare providers. In South Korea, the market for asthma monitoring devices will continue to be developed and expand as awareness of asthma and guided disease management continues to surface. With smartphones being widely adopted, connected technologies are being embraced in South Korea, partly due to the telehealth support structure already in place, and with some connected technologies integrated with electronic health records (EHRs). Hospitals, clinics, and homecare settings are deploying asthma monitoring devices to keep patient adherent, prevent exacerbations, and ultimately improving patient outcomes, that will position the asthma monitoring device market for continued growth throughout the forecast period.

 

Report Coverage

This research report categorizes the market for the South Korea asthma monitoring devices market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea asthma monitoring devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea asthma monitoring devices market.

 

South Korea Asthma Monitoring Devices Market Report Coverage

Report CoverageDetails
Base Year:2024
Forecast Period:2024-2035
Forecast Period CAGR 2024-2035 : 5.5%
Historical Data for:2020-2023
No. of Pages:139
Tables, Charts & Figures:150
Segments covered:By Product Type, By Technology.
Companies covered:: Philips Healthcare, ResMed Inc., 3M Company, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Novartis AG, Merck & Co., Inc., and Others.
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The South Korea asthma monitoring devices market is driven by increased incidence of asthma, demand for home monitoring, and emerging connected health technologies. Asthma monitoring devices are supported by a strong telehealth infrastructure, extensive smartphone usage, and government initiatives to utilize digital health technologies. Considering various payers are heavily crusading to cut back visits to hospitals and to also increase adherence, the market evolution continues to strengthen.

 

Restraining Factors

South Korea Asthma Monitoring Devices Market, restraints include lack of reimbursement, high device prices, and data privacy concerns. Insurance reimbursement is limited and varies physicianby physician. Issues with physician adoption is often down to a lack of good clinical data to report on and standardize, making adoption into practice much harder.

 

Market Segmentation

The South Korea asthma monitoring devices market share is classified into product type and technology.

 

  • The peak flow meters segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea asthma monitoring devices market is segmented by product type into peak flow meters, smart inhalers, nebulizers, wearable devices, and others. Among these, the peak flow meters segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. Peak flow meters are inexpensive, easy to use, and commonly recommended for patients as part of routine asthma monitoring practices; thus, they are the most accessible option for patients. Smart inhalers and wearables are seen as developing options because they provide digital connectively and adherence tracking for monitoring; while nebulizers are still important for severe asthma management.

 

  • The digital segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea asthma monitoring devices market is segmented by technology into digital and manual devices. Among these, the digital segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period. Digital devices provide shareable data immediately, connectivity with telehealth applications, and enhanced adherence monitoring, which are driving their accelerated adoption. Manual devices are still used because of their low price point and simplicity, but they are being phased out as the healthcare system and patients moves to connectivity.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea asthma monitoring devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Philips Healthcare
  • ResMed Inc.
  • 3M Company
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries Ltd.
  • AstraZeneca plc
  • Novartis AG
  • Merck & Co., Inc.
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea Asthma Monitoring Devices Market based on the below-mentioned segments:

 

South Korea Asthma Monitoring Devices Market, By Product Type

  • Peak Flow Meters
  • Smart Inhalers
  • Nebulizers
  • Wearable Devices
  • Others

 

South Korea Asthma Monitoring Devices Market, By Technology

  • Digital
  • Manual

Frequently Asked Questions (FAQ)

  • 1. What is the growth outlook for the South Korea Asthma Monitoring Devices Market?
    The market is expected to grow at a CAGR of 5.5% during the forecast period 2025–2035, driven by rising asthma prevalence, home-based monitoring demand, and adoption of connected health technologies.
  • 2. What factors are driving the market growth?
    Key drivers include increasing incidence of asthma, high smartphone usage, expanding telehealth infrastructure, and payer focus on reducing hospital visits while improving adherence.
  • 3. What are the major restraints in the market?
    The market faces challenges such as limited reimbursement, high device costs, data privacy concerns, and variability in physician adoption due to insufficient standardized clinical evidence.
  • 4. Which product type dominates the market?
    The peak flow meters segment held the largest share in 2024 and is expected to grow significantly due to affordability, ease of use, and wide recommendation for routine asthma monitoring.
  • 5. Which technology segment leads the market?
    The digital segment dominated the market in 2024 and is projected to grow rapidly because of real-time data sharing, telehealth integration, and improved adherence monitoring.
  • 6. Who are the key players in the South Korea Asthma Monitoring Devices Market?
    Major companies include Philips Healthcare, ResMed Inc., 3M Company, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Novartis AG, and Merck & Co., Inc., and Others.

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies